SAB Biotherapeutics

SABSSAB Biotherapeutics

About SAB Biotherapeutics

SAB Biotherapeutics (NASDAQ: SABS) pioneers groundbreaking biotechnology solutions with a focus on human antibodies. Their proprietary SAB CAP Technology™ enables the development of fully human polyclonal antibodies without human donors, promising breakthroughs in treating infectious diseases, autoimmune disorders, and cancer. The company's clinical-stage initiatives, such as human anti-thymocyte immunoglobulin (hIgG) for type 1 diabetes, underscore their commitment to advancing healthcare. With a robust immunotherapy platform and a dedication to innovation, SAB Biotherapeutics stands poised to reshape medical treatments and address critical global health challenges, offering hope for improved patient outcomes worldwide.

What is SABS known for?

Snapshot

Public US

Ownership

2014

Year founded

Employees

Sioux Falls, United States

Head office

Loading Map...

Operations

All Locations

United States

Products and/or services of SAB Biotherapeutics

Fully Human Polyclonal Antibodies: SAB Biotherapeutics specializes in the development of fully human polyclonal antibodies using their innovative technology platform.
Immunotherapy Platform: The company offers a cutting-edge immunotherapy platform for the development of novel therapeutic solutions targeting various diseases, including infectious diseases, autoimmune disorders, and cancer.
Clinical-Stage Therapeutics: SAB Biotherapeutics may have clinical-stage therapeutic candidates targeting specific diseases or medical conditions, such as type 1 diabetes (T1D), utilizing their human anti-thymocyte immunoglobulin (hIgG).
Research and Development Services: SAB Biotherapeutics might offer research and development services, including collaboration opportunities with pharmaceutical companies, academic institutions, and research organizations.
Antibody Production Technologies: The company could provide technologies and expertise related to antibody production, purification, and characterization, leveraging their proprietary methods for scalable and cost-effective manufacturing.
Biotechnology Solutions: SAB Biotherapeutics likely offers a range of biotechnology solutions aimed at advancing medical research, drug discovery, and therapeutic development, with a focus on improving patient outcomes and addressing unmet medical needs.